Maladies complexes

Description

COVID longue

maladies_complexes_covid_longue via biblio.chum on Inoreader

Long COVID-19: Impact of a personalized rehabilitation program
on 31 mars 2025
Rehabilitacion (Madr). 2025 Mar 28;59(2):100903. doi: 10.1016/j.rh.2025.100903. Online ahead of print.ABSTRACTINTRODUCTION: Several guidelines have proposed specific rehabilitation programs to treat symptoms/sequelae in patients with post-acute […]
Reorganization of brain connectivity in post-COVID condition: a (18)F-FDG PET study
on 31 mars 2025
EJNMMI Res. 2025 Mar 30;15(1):28. doi: 10.1186/s13550-025-01217-7.ABSTRACTBACKGROUND: A hypometabolic brain pattern has been reported in patients with post-COVID condition (PCC). The aim of this study was to investigate reorganization in metabolic […]
Identifying risk factors and predicting long COVID in a Spanish cohort
on 31 mars 2025
Sci Rep. 2025 Mar 28;15(1):10758. doi: 10.1038/s41598-025-94765-w.ABSTRACTMany studies have investigated symptoms, comorbidities, demographic factors, and vaccine effects in relation to long COVID (LC-19) across global populations. However, a number […]
Effectiveness and tolerance of exercise interventions for long COVID: a systematic review of randomised controlled trials
on 31 mars 2025
BMJ Open. 2025 Mar 22;15(3):e082441. doi: 10.1136/bmjopen-2023-082441.ABSTRACTOBJECTIVES: To examine the effectiveness of exercise interventions to improve long COVID symptoms and the tolerance of exercise interventions among people with long […]
Vitamin B12 as an epidrug for regulating peripheral blood biomarkers in long COVID-associated visuoconstructive deficit
on 31 mars 2025
Sci Rep. 2025 Mar 19;15(1):9438. doi: 10.1038/s41598-025-86637-0.ABSTRACTApproximately four months after recovering from a mild COVID-19 infection, around 25% of individuals developed visuoconstructive deficit (VCD), which was found to be correlated […]
Long COVID: emerging pathophysiological mechanisms
on 31 mars 2025
Minerva Med. 2025 Mar 19. doi: 10.23736/S0026-4806.25.09539-4. Online ahead of print.ABSTRACTPost-COVID conditions, also termed "long COVID," are a heterogeneous set of conditions persisting greater than 28 days after initial infection. These […]
Altered auditory brainstem responses are post-acute sequela of SARS-CoV-2 (PASC)
on 31 mars 2025
Sci Rep. 2025 Mar 18;15(1):9387. doi: 10.1038/s41598-025-93664-4.ABSTRACTThe Post-acute Sequela of SARS-CoV-2 (PASC) syndrome, also known as Long-COVID, often presents with subjective symptoms such as brain fog and cognitive fatigue. Increased […]
Socioeconomic disparities in long COVID diagnosis among ethnic minorities in Denmark
on 31 mars 2025
Soc Sci Med. 2025 Mar 10;372:117944. doi: 10.1016/j.socscimed.2025.117944. Online ahead of print.ABSTRACTBACKGROUND: Low socioeconomic status has been demonstrated as a risk factor for COVID-19 severity and mortality. However, whether socioeconomic […]
Spatial transcriptomics of the epipharynx in long COVID identifies SARS-CoV-2 signalling pathways and the therapeutic potential of epipharyngeal abrasive therapy
on 31 mars 2025
Sci Rep. 2025 Mar 12;15(1):8618. doi: 10.1038/s41598-025-92908-7.ABSTRACTIn this study, the critical role of the epipharynx in managing long-term coronavirus disease 2019 (COVID-19), and in particular, how residual SARS-CoV-2 RNA affects signalling […]
The legacy of the COVID-19 pandemic for the healthcare environment: the establishment of long COVID/ Post-COVID-19 condition follow-up outpatient clinics in Germany
on 31 mars 2025
BMC Health Serv Res. 2025 Mar 10;25(1):360. doi: 10.1186/s12913-025-12521-2.ABSTRACTBACKGROUND: Since 2020, several specialized follow-up outpatient clinics have been established across Germany to address the complex needs of patients with Long […]
The 2024 National Academies of Sciences, Engineering, and Medicine Long COVID Definition: What Clinicians Need to Know
on 31 mars 2025
J Gen Intern Med. 2025 Mar 10. doi: 10.1007/s11606-025-09415-8. Online ahead of print.ABSTRACTMillions of Americans affected by Long COVID (LC) report difficulty accessing care and support. One barrier is obtaining a diagnosis. In response, US […]
Long COVID and new onset disability nearly two years after initial infection
on 31 mars 2025
Am J Prev Med. 2025 Mar 5:S0749-3797(25)00076-5. doi: 10.1016/j.amepre.2025.02.013. Online ahead of print.ABSTRACTINTRODUCTION: The objective of this study was to determine the prevalence of ongoing Long COVID symptoms and related disability in a […]
Analysis of risk factors for long COVID after mild COVID-19 during the Omicron wave in Japan
on 31 mars 2025
Respir Investig. 2025 Mar 5;63(3):303-310. doi: 10.1016/j.resinv.2025.02.008. Online ahead of print.ABSTRACTBACKGROUND: Post-COVID-19 syndrome, referred to as "long COVID," is characterized by persistent symptoms that develop during or after […]
Lung inflammation drives Long Covid
on 31 mars 2025
Science. 2025 Mar 7;387(6738):1039-1040. doi: 10.1126/science.adw0091. Epub 2025 Mar 6.ABSTRACTPeroxisome dysfunction in macrophages impairs lung repair after COVID-19 in mice.PMID:40048542 | DOI:10.1126/science.adw0091
Use and Characteristics of Clinical Coding for Post-COVID Conditions in a Retrospective US Cohort
on 31 mars 2025
J Public Health Manag Pract. 2025 Mar 5. doi: 10.1097/PHH.0000000000002137. Online ahead of print.ABSTRACTCONTEXT: Little is known about when and how the ICD-10-CM diagnosis code for Post-COVID Conditions (PCC; U09.9) is being used to document […]
Effect of Lithium Therapy on Long COVID Symptoms
on 31 mars 2025
Conditions: Long COVID Interventions: Drug: Lithium; Drug: Placebo Sponsors: State University of New York at Buffalo; National Center for Advancing Translational Sciences (NCATS) Completed
Genetic Landscape and Mitochondrial Metabolic Dysregulation in Patients Suffering From Severe Long COVID
on 3 mars 2025
J Med Virol. 2025 Mar;97(3):e70275. doi: 10.1002/jmv.70275.ABSTRACTLong COVID represents a significant global health challenge with an unclear etiology. Alongside accumulating evidence of mitochondrial dysfunction in patients with acute SARS-CoV-2 […]
Respiratory long COVID in aged hamsters features impaired lung function post-exercise with bronchiolization and fibrosis
on 3 mars 2025
Nat Commun. 2025 Feb 28;16(1):2080. doi: 10.1038/s41467-025-57267-x.ABSTRACTLong-term consequences of SARS-CoV-2 infection affect millions of people and strain public health systems. The underlying pathomechanisms remain unclear, necessitating […]
Rehabilitation interventions and outcomes for post-COVID condition: a scoping review
on 3 mars 2025
BMJ Public Health. 2025 Feb 26;3(1):e001827. doi: 10.1136/bmjph-2024-001827. eCollection 2025 Jan.ABSTRACTOBJECTIVE: Several rehabilitation interventions have been proposed to support people with post-COVID-19 condition (PCC). However, the full […]
Post-COVID-19 condition in prospective inpatient and outpatient cohorts
on 3 mars 2025
Sci Rep. 2025 Feb 26;15(1):6925. doi: 10.1038/s41598-025-90819-1.ABSTRACTViral persistence, immune dysregulation, hypocortisolism, and pulmonary tissue damage from acute infection are proposed as pathogenic mechanisms underlying post-COVID-19 […]

COVID longue : lignes directrices canadiennes

Mise à jour du 5 mars 2025

Mise à jour du 31 mars 2025

Maladie de Lyme

maladies_complexes_lyme via biblio.chum on Inoreader

Confusing variety of symptoms: Lyme carditis coinciding with Puumala hantavirus infection
on 31 mars 2025
Diagn Microbiol Infect Dis. 2025 Jun;112(2):116784. doi: 10.1016/j.diagmicrobio.2025.116784. Epub 2025 Mar 1.ABSTRACTThe temporal coincidence of a tick- and rodent-associated disease led to a confusing variety of symptoms, which posed diagnostic […]
Lower Frequency of Multiple Erythema Migrans Skin Lesions in Lyme Reinfections, Europe
on 31 mars 2025
Emerg Infect Dis. 2025 Apr;31(4):662-668. doi: 10.3201/eid3104.241329.ABSTRACTThe erythema migrans (EM) skin lesion is the most common clinical manifestation of Lyme borreliosis. Information about EM in Lyme borreliosis reinfection is limited. Of […]
UHPLC-MS/MS-based untargeted metabolite profiling of Lyme neuroborreliosis
on 31 mars 2025
Sci Rep. 2025 Mar 11;15(1):8442. doi: 10.1038/s41598-025-92189-0.ABSTRACTThe diagnosis of Lyme neuroborreliosis (LNB) requires the demonstration of intrathecal synthesis of Borrelia antibodies in a patient's cerebrospinal fluid (CSF), which involves […]
Adult-Onset Still's Disease (AOSD) in Patient with Previous Lyme Disease
on 31 mars 2025
J Brown Hosp Med. 2025 Jan 1;4(1):16-19. doi: 10.56305/001c.124992. eCollection 2025.ABSTRACTAdult-onset Still's Disease (AOSD) is a rare autoimmune disorder causing systemic inflammation that presents with a rash, fever, polyarthritis, and a […]
Borrelia spielmanii-Associated Neuroborreliosis in Patient Receiving Rituximab, Belgium
on 3 mars 2025
Emerg Infect Dis. 2025 Feb;31(2):341-344. doi: 10.3201/eid3102.240777.ABSTRACTA 58-year-old woman in Belgium with a history of follicular lymphoma treated with rituximab sought care for a rapid sensory-motor deficit. Seronegative neuroborreliosis […]
Borrelia burgdorferi serine protease HtrA is a pleiotropic regulator of stress response, motility, flagellar hemostasis, and infectivity
on 3 mars 2025
Commun Biol. 2025 Mar 1;8(1):341. doi: 10.1038/s42003-025-07781-x.ABSTRACTHigh-temperature requirement protease A (HtrA) is a family of serine proteases that regulate bacterial stress response through controlling protein quality. This report shows […]
A type-specific B-cell epitope at the apex of outer surface protein C (OspC) of the Lyme disease spirochete, Borreliella burgdorferi
on 3 mars 2025
Microbiol Spectr. 2025 Feb 14:e0288324. doi: 10.1128/spectrum.02883-24. Online ahead of print.ABSTRACTBroadly protective immunity to the Lyme disease spirochete, Borreliella burgdorferi, is constrained by antibodies against type-specific epitopes on […]
Borréliose de Lyme et autres maladies vectorielles à tiques : la HAS actualise ses recommandations - Haute Autorité de Santé
on 3 mars 2025
Borréliose de Lyme et autres maladies vectorielles à tiques : la HAS actualise ses recommandations Haute Autorité de Santé
Dose Evaluation and Optimization of Amoxicillin in Children Treated for Lyme Disease
on 13 février 2025
J Clin Pharmacol. 2025 Jan 27. doi: 10.1002/jcph.6190. Online ahead of print.ABSTRACTAmoxicillin is commonly used to treat erythema migrans in the first stage of Lyme disease in children, with a recommended dose of 50 mg/kg/day, administered three […]
Lyme disease associated neurological and musculoskeletal symptoms: A systematic review and meta-analysis
on 13 février 2025
Brain Behav Immun Health. 2025 Jan 2;43:100931. doi: 10.1016/j.bbih.2024.100931. eCollection 2025 Feb.ABSTRACTBACKGROUND AND OBJECTIVE: Lyme disease, caused by Borrelia burgdorferi, presents major health challenges worldwide, leading to serious […]
Lyme neuroborreliosis in Japan: Borrelia burgdorferi sensu lato as a cause of meningitis of previously undetermined etiology in hospitalized patients outside of the island of Hokkaido, 2010-2021
on 15 janvier 2025
Eur J Neurol. 2025 Jan;32(1):e70005. doi: 10.1111/ene.70005.ABSTRACTBACKGROUND AND PURPOSE: Clinical manifestations of Lyme borreliosis (LB), caused by Borrelia burgdorferi sensu lato (Bbsl), include erythema migrans, Lyme neuroborreliosis (LNB), […]
Perspective: Incidence of Clinician-Diagnosed Lyme Disease in Manitoba, Canada 2009-2018
on 15 janvier 2025
Vector Borne Zoonotic Dis. 2025 Jan 6. doi: 10.1089/vbz.2024.0088. Online ahead of print.ABSTRACTIntroduction: Lyme disease (LD) surveillance yields useful information to monitor the disease trends and spatial distribution. However, due to several […]
Clinical characteristics and serological profiles of Lyme disease in children: a 15-year retrospective cohort study in Switzerland
on 15 janvier 2025
Lancet Reg Health Eur. 2024 Dec 9;48:101143. doi: 10.1016/j.lanepe.2024.101143. eCollection 2025 Jan.ABSTRACTBACKGROUND: Lyme disease (LD) is caused by Borrelia burgdorferi and is the most common tickborne disease in the northern hemisphere. […]
The Current and Future State of Vaccines for Lyme Disease
on 15 janvier 2025
Clin Infect Dis. 2024 Dec 23:ciae639. doi: 10.1093/cid/ciae639. Online ahead of print.ABSTRACTLyme disease is caused by Borrelia species that are transmitted by Ixodes ticks prevalent in parts of the United States and Europe. A Lyme vaccine […]
bb0689 contributes to the virulence of Borrelia burgdorferi in a murine model of Lyme disease
on 20 Décembre 2024
Infect Immun. 2024 Dec 16:e0045924. doi: 10.1128/iai.00459-24. Online ahead of print.ABSTRACTBorrelia burgdorferi, the Lyme disease pathogen, continuously changes its gene expression profile in order to adapt to ticks and mammalian hosts. The […]
Broadly conserved FlgV controls flagellar assembly and Borrelia burgdorferi dissemination in mice
on 20 Décembre 2024
Nat Commun. 2024 Nov 29;15(1):10417. doi: 10.1038/s41467-024-54806-w.ABSTRACTFlagella propel pathogens through their environments, yet are expensive to synthesize and are immunogenic. Thus, complex hierarchical regulatory networks control flagellar […]
Anti-RA33 Antibodies Are Present in Patients With Lyme Disease
on 20 Décembre 2024
J Clin Rheumatol. 2024 Nov 22. doi: 10.1097/RHU.0000000000002176. Online ahead of print.ABSTRACTBACKGROUND/OBJECTIVE: To determine if anti-RA33 antibodies, which can be seen in early forms of inflammatory arthritis, are present in patients with Lyme […]
Historical Summary of Tick and Animal Surveillance Studies for Lyme Disease in Canada, 1975-2023: A Scoping Review
on 20 Décembre 2024
Zoonoses Public Health. 2024 Nov 22. doi: 10.1111/zph.13191. Online ahead of print.ABSTRACTINTRODUCTION: Lyme disease (LD) is caused by infection with the bacteria Borrelia burgdorferi sensu lato (Bb) through the bite of an infected Ixodes spp. […]
Upcoming Events - Lyme Care Resource Center
on 15 novembre 2024
Invalidation, gender, and the medical encounter in Lyme disease Tuesday, November 19th, 2024, 7:00- 8:30pm EST Alison Rebman, MPH earned her graduate degree from Columbia University in Sociomedical Sciences. She is currently an […]
Identifying the geographic leading edge of Lyme disease in the United States with internet searches: A spatiotemporal analysis of Google Health Trends data
on 15 novembre 2024
PLoS One. 2024 Nov 13;19(11):e0312277. doi: 10.1371/journal.pone.0312277. eCollection 2024.ABSTRACTBACKGROUND: The geographic footprint of Lyme disease is expanding in the United States, which calls for novel methods to identify emerging endemic […]

Encéphalomyélite myalgique

maladies_complexes_encephalomyelite via biblio.chum on Inoreader

PKM2 accelerated the progression of chronic fatigue syndrome via promoting the H4K12la/ NF-kappaB induced neuroinflammation and mitochondrial damage
on 31 mars 2025
Sci Rep. 2025 Mar 28;15(1):10772. doi: 10.1038/s41598-025-93313-w.ABSTRACTThis study aims to explore the effects and potential mechanisms of PKM2-mediated neuroinflammation leading to mitochondrial damage and its role in the progression of chronic […]
A research perspective on sphingolipid metabolism and myalgic encephalomyelitis/chronic fatigue syndrome
on 31 mars 2025
Neural Regen Res. 2025 Mar 25. doi: 10.4103/NRR.NRR-D-24-01506. Online ahead of print.NO ABSTRACTPMID:40145965 | DOI:10.4103/NRR.NRR-D-24-01506
Improving myalgic encephalomyelitis population sampling: Applying an online respondent-driven method to address biases in G93.3 register data
on 31 mars 2025
J Health Psychol. 2025 Mar 24:13591053251325690. doi: 10.1177/13591053251325690. Online ahead of print.ABSTRACTWith widespread late- and under-diagnosing, health register code G93.3 data cannot offer an unbiased sampling frame for myalgic […]
Voice of the patient: people with myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) share in their own words
on 31 mars 2025
Fatigue. 2025;13(2):1-11. doi: 10.1080/21641846.2024.2444826.ABSTRACTBACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a serious, debilitating illness affecting millions of people worldwide. Patients with ME/CFS often feel […]
Assessing fatigue in myalgic encephalomyelitis/chronic fatigue syndrome patients before and after treatment with bright light therapy: A prospective randomized controlled crossover study
on 31 mars 2025
Sleep Med. 2025 Mar 14;129:369-374. doi: 10.1016/j.sleep.2025.03.003. Online ahead of print.ABSTRACTOBJECTIVE: The aim of the current study was to test the effectiveness of treatment with bright light therapy (BLT) on fatigue and cognitive function […]
Under-Served Groups and Myalgic Encephalomyelitis Research Workshop; Multiple Barriers to Effective Healthcare, Research and Public Participation
on 31 mars 2025
Health Expect. 2025 Apr;28(2):e70214. doi: 10.1111/hex.70214.ABSTRACTPublic involvement in research and other initiatives for myalgic encephalomyelitis (ME) (also known as chronic fatigue syndrome) has been crucial in raising awareness of the […]
Post-infective myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and post-COVID as two puzzling faces of the same medal. Recent insights
on 31 mars 2025
Int Immunopharmacol. 2025 Mar 7:114365. doi: 10.1016/j.intimp.2025.114365. Online ahead of print.NO ABSTRACTPMID:40057420 | DOI:10.1016/j.intimp.2025.114365
Mapping the Complexity of ME/CFS: Evidence for Abnormal Energy Metabolism, Altered Immune Profile and Vascular Dysfunction
on 3 mars 2025
Author Names: Heng R.B.,Gunasegaran B.,Krishnamurthy S.,Bustamante S.,Pires A.S.,Chow S.,Ahn S.B.,Paul-Heng M.,Maciver Y.,Smith K.,Tran D.P.,Howley P.P.,Bilgin A.A.,Sharland A.,Schloeffel R.,Guillemin G.J. Database Source: […]
Chronic Fatigue Syndrome: Pulling Back the Curtains
on 3 mars 2025
Author Names: anonymous Database Source: Embase Daily Updates Journal Title: The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry Article […]
A comparison of genome-wide association analyses of persistent symptoms after Lyme disease, fibromyalgia, and myalgic encephalomyelitis - chronic fatigue syndrome
on 3 mars 2025
Author Names: Hirsch A.G.,Justice A.E.,Poissant A.,Nordberg C.M.,Josyula N.S.,Aucott J.,Rebman A.W.,Schwartz B.S. Database Source: Embase Daily Updates Journal Title: BMC Infectious Diseases […]
Cerebrospinal fluid metabolomics, lipidomics and serine pathway dysfunction in myalgic encephalomyelitis/chronic fatigue syndroome (ME/CFS)
on 3 mars 2025
Sci Rep. 2025 Mar 3;15(1):7381. doi: 10.1038/s41598-025-91324-1.ABSTRACTWe proposed that cerebrospinal fluid would provide objective evidence for disrupted brain metabolism in myalgic encephalomyelitis/chronic fatigue syndroome (ME/CFS). The concept […]
A comparison of genome-wide association analyses of persistent symptoms after Lyme disease, fibromyalgia, and myalgic encephalomyelitis - chronic fatigue syndrome
on 3 mars 2025
BMC Infect Dis. 2025 Feb 24;25(1):265. doi: 10.1186/s12879-024-10238-x.ABSTRACTBACKGROUND: Up to 20% of Lyme disease cases experience post-treatment Lyme disease syndrome (PTLDS). The biological basis for PTLDS is poorly understood and no […]
Managing Energy, and Shaping Care: Insights from Adults with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Through Co-Production Workshops
on 3 mars 2025
Am J Med. 2025 Feb 15:S0002-9343(25)00093-2. doi: 10.1016/j.amjmed.2025.02.008. Online ahead of print.ABSTRACTBACKGROUND: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex, debilitating condition characterised by severe […]
Cognitive functioning in patients with chronic fatigue syndrome: Slowed information processing or a deficit in attentional selectivity?
on 3 mars 2025
Neuropsychology. 2025 Feb;39(2):152-161. doi: 10.1037/neu0000982.ABSTRACTOBJECTIVE: By addressing numerous statistical, theoretical, and methodological weaknesses of existing research on chronic fatigue syndrome (CFS), this study attempted to […]
Abnormal T-Cell Activation And Cytotoxic T-Cell Frequency Discriminates Symptom Severity In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
on 11 février 2025
medRxiv [Preprint]. 2025 Jan 6:2025.01.02.24319359. doi: 10.1101/2025.01.02.24319359.ABSTRACTMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating but poorly-understood disease. ME/CFS symptoms can range from mild to severe, […]
Provocation of brachial plexus and systemic symptoms during the elevated arm stress test in individuals with myalgic encephalomyelitis/chronic fatigue syndrome or idiopathic chronic fatigue
on 11 février 2025
J Transl Med. 2025 Jan 22;23(1):106. doi: 10.1186/s12967-025-06137-7.ABSTRACTBACKGROUND: We have noted that some adolescents and young adults with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) report difficulty with arms-overhead […]
The search for a blood-based biomarker for Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS): from biochemistry to electrophysiology
on 11 février 2025
J Transl Med. 2025 Feb 4;23(1):149. doi: 10.1186/s12967-025-06146-6.ABSTRACTBACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a disease of unknown aetiology characterised by symptoms of post-exertional malaise (PEM) and […]
Chronic Fatigue Syndrome: Pulling Back the Curtains
on 11 février 2025
Neuroscientist. 2025 Feb;31(1):5. doi: 10.1177/10738584241308723.NO ABSTRACTPMID:39927439 | DOI:10.1177/10738584241308723
Exercise therapy for chronic fatigue syndrome - PubMed
on 15 janvier 2025
Editorial note: Editorial note (19 December 2024): Larun L, Brurberg KG, Odgaard‐Jensen J, Price JR. Exercise therapy for chronic fatigue syndrome. Cochrane Database of Systematic Reviews 2019, Issue 10. Art. No.: CD003200. DOI: […]
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study
on 15 janvier 2025
J Gen Intern Med. 2025 Jan 13. doi: 10.1007/s11606-024-09290-9. Online ahead of print.ABSTRACTBACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may occur after infection. How often people develop ME/CFS after SARS-CoV-2 […]

Syndrome d'Ehlers-Danlos

maladies_complexes_syndrome_ehlers_danlos 2 via biblio.chum on Inoreader

Autism in the context of joint hypermobility, hypermobility spectrum disorders, and Ehlers-Danlos syndromes: A systematic review and prevalence meta-analyses
on 31 mars 2025
Autism. 2025 Mar 27:13623613251328059. doi: 10.1177/13623613251328059. Online ahead of print.ABSTRACTIncreasing research suggests a link between autism spectrum disorders and joint hypermobility, hypermobility spectrum disorders, and Ehlers-Danlos […]
Prevalence of psychiatric and sleep disorders and their impact on quality of life in children with hypermobile Ehlers-Danlos syndrome: an observational study
on 31 mars 2025
Rheumatol Int. 2025 Mar 25;45(4):81. doi: 10.1007/s00296-025-05836-0.ABSTRACTHypermobile Ehlers-Danlos Syndrome (hEDS) is the most common connective tissue disorder. However, few studies exist on psychiatric and sleep disorders in pediatric patients […]
Pregnancy and Delivery Outcomes in Vascular Ehlers-Danlos Syndrome: A Retrospective Multicentre Cohort Study
on 31 mars 2025
BJOG. 2025 Mar 19. doi: 10.1111/1471-0528.18142. Online ahead of print.ABSTRACTOBJECTIVE: We aim to increase knowledge on pregnancy and delivery risks in vascular Ehlers-Danlos Syndrome (vEDS). Our outcomes can contribute to establishing future […]
Shaping the future of care for patients with Ehlers-Danlos syndromes: from multidisciplinary management to precision medicine
on 31 mars 2025
Orphanet J Rare Dis. 2025 Mar 3;20(1):98. doi: 10.1186/s13023-025-03615-5.NO ABSTRACTPMID:40033344 | DOI:10.1186/s13023-025-03615-5
Radiographic identification of visceroptosis in hypermobile Ehlers-Danlos syndrome patients with functional gastrointestinal symptoms compared to healthy subjects
on 31 mars 2025
Clin Transl Gastroenterol. 2025 Mar 3. doi: 10.14309/ctg.0000000000000834. Online ahead of print.ABSTRACTINTRODUCTION: Visceroptosis is a potential cause of gastrointestinal symptoms in hypermobile Ehlers-Danlos syndrome (hEDS).METHODS: We […]

Études cliniques

maladies_complexes_etudes_cliniques via biblio.chum on Inoreader

Long-term Symptomatic Follow-up of Patients with Long COVID Syndrome
on 31 mars 2025
Conditions: Long COVID Sponsors: Hospital del Rio Hortega Active, not recruiting
NENCA Study on Neurological Complications of Long COVID-19 in Children and Adolescents; Neurophysiological, Electroencephalographic and Neuroradiological Investigation
on 31 mars 2025
Conditions: Long Covid-19 Interventions: Diagnostic Test: Psychological tests, EEG, Magnetic Resonance Sponsors: Azienda Ospedaliero, Universitaria Pisana Recruiting
Physiological and QoL Benefits of Qi-Gong in Post-acute Sequelae of Covid-19
on 31 mars 2025
Conditions: PASC Post Acute Sequelae of COVID 19 Interventions: Behavioral: QI-GONG and control Sponsors: POCHIWU Recruiting
Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID
on 31 mars 2025
Conditions: Long-COVID; PASC; Long COVID Syndrome Interventions: Other: Osteopathic Manipulative Therapy Long-COVID protocol; Other: Osteopathic Manipulative Therapy NOT Long-COVID treatment protocol Sponsors: University of Louisville Recruiting
Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT and SPIKEVAX X Injection.
on 31 mars 2025
Conditions: SARS-CoV-2 Interventions: Biological: SPIKEVAX Bivalent; Biological: SPIKEVAX X Sponsors: ModernaTX, Inc. Recruiting
Predictors of Post-COVID-19 Clinical and Cognitive Consequences
on 31 mars 2025
Conditions: Post Acute Sequelae of SARS CoV 2 Infection; Obstructive Sleep Apnea Sponsors: VA Office of Research and Development; John D. Dingell VA Medical Center Recruiting
Cardiopulmonary Rehabilitation in Post-acute COVID-19 Syndrome
on 31 mars 2025
Conditions: Post Acute COVID-19 Syndrome Interventions: Other: Cardiopulmonary rehabilitation; Other: Health education Sponsors: Taipei Medical University Shuang Ho Hospital Withdrawn
"Long COVID-19" on the Human Brain
on 31 mars 2025
Conditions: COVID-19; Long Covid; Post Acute Sequelae of COVID-19 Interventions: Other: MRI and PET Scans Sponsors: Centre for Addiction and Mental Health; Sunnybrook Health Sciences Centre Completed
Characteristics of Long COVID-19 Syndrome
on 31 mars 2025
Conditions: Long COVID Syndrome Interventions: Other: No intervention Sponsors: Christian Clarenbach Active, not recruiting
Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID
on 31 mars 2025
Conditions: Post Acute COVID-19 Syndrome; Long COVID; Long Covid19; COVID-19 Recurrent; Post-Acute COVID-19; Post-Acute COVID-19 Infection; SARS-CoV2 Infection; Post Acute Sequelae of COVID-19; Dysautonomia; Dysautonomia Like Disorder; Dysautonomia […]
Sequelae of Sars-CoV-2 Infections
on 31 mars 2025
Conditions: Lung Diseases; Cardiac Disease; Inflammatory Reaction Sponsors: University of Giessen Recruiting
Telerehabilitation in People With Long COVID
on 31 mars 2025
Conditions: COVID-19 Interventions: Device: Home-based telerehabilitation; Behavioral: Education and self-exercise Sponsors: Tri-Service General Hospital Completed
Evaluating the Impact of a Functional and Cognitive Strategy in Patients with Long Covid-19
on 31 mars 2025
Conditions: Long COVID-19 Syndrome; COVID 19; Noncommunicable Disease; Hypertension; Diabetes Mellitus; Long COVID Interventions: Other: Functional and cognitive rehabilitation strategy; Other: Evidence-Based Informational Support Sponsors: […]
Evaluation of MicroRNAs and Vitamin B12 Expression in Subjects with Neurologic Symptoms of Depression, Anxiety and Fatigue in Long COVID-19
on 31 mars 2025
Conditions: Long COVID; Long COVID Syndrome Sponsors: Instituto Nacional de Rehabilitacion Recruiting
Register Study: Implementation of Pharyngeal Electrostimulation Therapy for the Treatment of Acute Neurogenic Dysphagia
on 31 mars 2025
Conditions: Neurogenic Dysphagia; Traumatic Brain Injury; Stroke; Dysphagia; Long Covid-19; Intubation Complication; Polyradiculitis Interventions: Device: Pharyngeal electrostimulation Sponsors: Karl Landsteiner University of Health Sciences; […]
Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy
on 31 mars 2025
Conditions: Traumatic Brain Injury; Fatigue; Cognitive Impairment; COVID-19 Interventions: Drug: Somatropin Sponsors: The University of Texas Medical Branch, Galveston Completed
Physical Activity Post COVID-19
on 3 mars 2025
Conditions: Covid19 Interventions: Behavioral: Physical activity Sponsors: University of Alcala; Professional College of Physiotherapists of the Community of Madrid (CPFCM); University Hospital of Guadalajara (HUGU) Completed
CISCO-21 Prevent and Treat Long COVID-19.
on 3 mars 2025
Conditions: Covid19 Interventions: Other: Resistance Exercise Sponsors: NHS Greater Glasgow and Clyde; University of Glasgow; Chief Scientist Office of the Scottish Government Completed
NE3107 in Adults with Long COVID
on 3 mars 2025
Conditions: Long COVID Interventions: Drug: NE3107; Drug: Placebo Sponsors: BioVie Inc. Not yet recruiting
Cognitive-Sensorimotor Function in Long-COVID
on 3 mars 2025
Conditions: Post-acute Sequelae of SARS-CoV-2 Infection Sponsors: VA Office of Research and Development; Edward Hines Jr. VA Hospital Not yet recruiting

Revue d'actualités

maladies_complexes_actualites via biblio.chum on Inoreader

Beyond long COVID — how reinfections could be causing silent long-term organ damage - CBC.ca
on 31 mars 2025
Beyond long COVID — how reinfections could be causing silent long-term organ damage CBC.ca
COVID longue : des manifestants veulent davantage de recherche - Radio-Canada.ca
on 31 mars 2025
COVID longue : des manifestants veulent davantage de recherche Radio-Canada.ca
Les dés pipés de la COVID longue - Le Soleil
on 31 mars 2025
Les dés pipés de la COVID longue Le Soleil
Quand la guerre contre la COVID longue se livre à trois - Radio-Canada.ca
on 31 mars 2025
Quand la guerre contre la COVID longue se livre à trois Radio-Canada.ca
Un sportif de 19 ans passe maintenant ses journées alité à cause de la COVID longue durée - Le Journal de Montréal
on 31 mars 2025
Un sportif de 19 ans passe maintenant ses journées alité à cause de la COVID longue durée Le Journal de Montréal
La COVID longue, un pénible héritage de la pandémie - Radio-Canada.ca
on 31 mars 2025
La COVID longue, un pénible héritage de la pandémie Radio-Canada.ca
COVID longue : « J’ai appris à vivre avec la maladie » - Radio-Canada.ca
on 31 mars 2025
COVID longue : « J’ai appris à vivre avec la maladie » Radio-Canada.ca
Encore une centaine de nouveaux cas de COVID longue durée chaque mois - Le Journal de Montréal
on 31 mars 2025
Encore une centaine de nouveaux cas de COVID longue durée chaque mois Le Journal de Montréal
La COVID longue, « est-ce que ça va être ça pour le reste de ma vie? » - Radio-Canada.ca
on 31 mars 2025
La COVID longue, « est-ce que ça va être ça pour le reste de ma vie? » Radio-Canada.ca
Dossier | La COVID-19, cinq ans plus tard | L’espoir au bout de la COVID longue (3 articles) - La Presse
on 31 mars 2025
Dossier | La COVID-19, cinq ans plus tard | L’espoir au bout de la COVID longue (3 articles) La Presse
5 ans après son apparition en Alberta, la COVID-19 continue de tuer - Radio-Canada.ca
on 31 mars 2025
5 ans après son apparition en Alberta, la COVID-19 continue de tuer Radio-Canada.ca
Santé. Maladie de Lyme : retour de la controverse médicale après de nouvelles recommandations de la HAS - Le Bien Public
on 31 mars 2025
Santé. Maladie de Lyme : retour de la controverse médicale après de nouvelles recommandations de la HAS Le Bien Public
Chronic fatigue syndrome: Outcry over Cochrane decision to abandon review of exercise therapy
on 3 mars 2025
A decision to cancel a planned update of a Cochrane systematic review of exercise therapy for chronic fatigue syndrome has met with anger from a group advising the review and the patient community.The decision has reignited calls for the review,1 […]
Maladie de Lyme : pourquoi les nouvelles recommandations de la HAS sont-elles controversées ? - Pourquoi Docteur ?
on 3 mars 2025
Maladie de Lyme : pourquoi les nouvelles recommandations de la HAS sont-elles controversées ? Pourquoi Docteur ?
‘We’re losing decades of our life to this illness’: long Covid patients on the fear of being forgotten
on 3 mars 2025
On 20 March 2020, Rowan Brown started to feel a tickle at the back of her throat. Over the next few days, new symptoms began to emerge: difficulty breathing, some tiredness. By the following week, the UK had been put under lockdown in a last-minute […]
Cinq ans de pandémie de COVID-19 en 7 chiffres - Le Devoir
on 3 mars 2025
Cinq ans de pandémie de COVID-19 en 7 chiffres Le Devoir
La COVID longue, toujours une énigme qui fait vivre l’enfer à ses victimes - La Voix de l'Est
on 3 mars 2025
La COVID longue, toujours une énigme qui fait vivre l’enfer à ses victimes La Voix de l'Est
L’odorat se fait parfois jouer des tours par le cerveau - Radio-Canada.ca
on 3 mars 2025
L’odorat se fait parfois jouer des tours par le cerveau Radio-Canada.ca
COVID-19 : tout sur la pandémie | Dossier - Radio-Canada.ca
on 3 mars 2025
COVID-19 : tout sur la pandémie | Dossier Radio-Canada.ca
Atteinte de la COVID longue, Isabelle Desbiens apprend à vivre avec la maladie - Radio-Canada.ca
on 3 mars 2025
Atteinte de la COVID longue, Isabelle Desbiens apprend à vivre avec la maladie Radio-Canada.ca

Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.

Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.

Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.

Avis de non-responsabilité

1. EXCLUSION DE GARANTIES ET LIMITATION DE RESPONSABILITÉ

Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit.

Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.

2. RESPONSABILITÉ RELATIVES AUX LIENS

Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées.

Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.

3. PROPRIÉTÉ INTELLECTUELLE

Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42).

Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité.

Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables.